Nutrient regulation of insulin secretion and action

Journal of Endocrinology

Volumn 221, Issue 3, 2014, Pages

  Newsholme, Philip ^a   Cruzat, Vinicius ^a   Arfuso, Frank ^a   Keane, Kevin ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

Diabetes; Inflammation; Insulin; Insulin resistance; Metabolism; Nutrients

Indexed keywords

AMINO ACID; CARBOHYDRATE; INSULIN; LIPID;

ADIPOSE TISSUE; AMINO ACID METABOLISM; BONE MARROW CELL; CARBOHYDRATE METABOLISM; CELL ACTIVATION; DIABETES MELLITUS; HUMAN; INFLAMMATION; INSULIN METABOLISM; INSULIN RELEASE; LIPID METABOLISM; LIVER; MACROPHAGE; METABOLIC REGULATION; MUSCLE; NONHUMAN; NUTRIENT; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE;

DIABETES; INFLAMMATION; INSULIN; INSULIN RESISTANCE; METABOLISM; NUTRIENTS;

DIABETES MELLITUS; EXOCYTOSIS; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIPID METABOLISM; MODELS, BIOLOGICAL; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; RISK FACTORS;

EID: 84901627098     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0616     Document Type: Review

References (138)

1. Alvarez E, Roncero I, Chowen JA, Vazquez P & Blazquez E 2002 Evidence that glucokinase regulatory protein is expressed and interacts with glucokinase in rat brain. Journal of Neurochemistry 80 45-53. (doi:10.1046/j.0022-3042.2001.00677.x)
2. Back SH, Kang S-W, Han J & Chung H-T 2012 Endoplasmic reticulum stress in the b-cell pathogenesis of type 2 diabetes. Experimental Diabetes Research 2012 618396-618396. (doi:10.1155/2012/618396)
3. Bedoya FJ, Wilson JM, Ghosh AK, Finegold D & Matschinsky FM 1986 The glucokinase glucose sensor in human pancreatic islet tissue. Diabetes 35 61-67. (doi:10.2337/diab.35.1.61)
4. Bender K, Maechler P, McClenaghan NH, Flatt PR & Newsholme P 2009 Overexpression of the malate-aspartate NADH shuttle member Aralar1 in the clonal b-cell line BRIN-BD11 enhances amino-acid-stimulated insulin secretion and cell metabolism. Clinical Science 117 321-330. (doi:10.1042/CS20090126)
5. Bending D, Zaccone P & Cooke A 2012 Inflammation and type one diabetes. International Immunology 24 339-346. (doi:10.1093/intimm/dxs049)
6. Berne C 1975 The metabolism of lipids in mouse pancreatic islets. The biosynthesis of triacylglycerols and phospholipids. Biochemical Journal 152 667-673.
7. Böni-Schnetzler M, Thorne J, Parnaud G, Marselli L, Ehses JA, Kerr-Conte J, Pattou F, Halban PA, Weir GC & Donath MY 2008 Increased interleukin (IL)-1b messenger ribonucleic acid expression in b-cells of individuals with type 2 diabetes and regulation of IL-1b in human islets by glucose and autostimulation. Journal of Clinical Endocrinology and Metabolism 93 4065-4074. (doi:10.1210/jc.2008-0396)
8. Brennan L, Shine A, Hewage C, Malthouse JP, Brindle KM, McClenaghan N, Flatt PR & Newsholme P 2002 A nuclear magnetic resonance-based demonstration of substantial oxidative L-alanine metabolism and L-alanine-enhanced glucose metabolism in a clonal pancreatic b-cell line: metabolism of L-alanine is important to the regulation of insulin secretion. Diabetes 51 1714-1721. (doi:10.2337/diabetes.51.6.1714)
9. Brennan L, Corless M, Hewage C, Malthouse JP, McClenaghan NH, Flatt PR & Newsholme P 2003 13C NMR analysis reveals a link between L-glutamine metabolism, D-glucose metabolism and g-glutamyl cycle activity in a clonal pancreatic b-cell line. Diabetologia 46 1512-1521. (doi:10.1007/s00125-003-1184-7)
10. Broca C, Brennan L, Petit P, Newsholme P & Maechler P 2003Mitochondriaderived glutamate at the interplay between branched-chain amino acid and glucose-induced insulin secretion. FEBS Letters 545 167-172. (doi:10.1016/S0014-5793(03)00526-X)
11. Burant CF, Viswanathan P, Marcinak J, Cao C, Vakilynejad M, Xie B & Leifke E 2012 TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet 379 1403-1411. (doi:10.1016/S0140-6736(11)61879-5)
12. Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO & Caicedo A 2006 The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. PNAS 103 2334-2339. (doi:10.1073/pnas.0510790103)
13. Carpentier A, Mittelman SD, Bergman RN, Giacca A & Lewis GF 2000 Prolonged elevation of plasma free fatty acids impairs pancreatic b-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Diabetes 49 399-408. (doi:10.2337/diabetes.49.3.399)
14. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB III, Kaestner KH, Bartolomei MS, Shulman GI & Birnbaum MJ 2001 Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB b). Science 292 1728-1731. (doi:10.1126/science.292. 5522.1728)
15. Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, Cooper GJ, Holman RR & Turner RC 1988 Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Research 9 151-159.
16. Cnop M 2008 Fatty acids and glucolipotoxicity in the pathogenesis of type 2 diabetes. Biochemical Society Transactions 36 348-352. (doi:10.1042/BST0360348)
17. Cnop M, Welsh N, Jonas J-C, Jorns A, Lenzen S & Eizirik DL 2005 Mechanisms of pancreatic b-cell death in type 1 and type 2 diabetes:many differences, few similarities. Diabetes 54(Suppl 2) 97-9107. (doi:10.2337/diabetes.54.suppl_2.S97)
18. Corcoran MP, Lamon-Fava S & Fielding RA 2007 Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise. American Journal of Clinical Nutrition 85 662-677.
19. Corless M, Kiely A, McClenaghan NH, Flatt PR & Newsholme P 2006 Glutamine regulates expression of key transcription factor, signal transduction, metabolic gene, and protein expression in a clonal pancreatic b-cell line. Journal of Endocrinology 190 719-727. (doi:10.1677/joe.1.06892)
20. Cruzat VF & Tirapegui J 2009 Effects of oral supplementation with glutamine and alanyl-glutamine on glutamine, glutamate, and glutathione status in trained rats and subjected to long-duration exercise. Nutrition 25 428-435. (doi:10.1016/j.nut.2008.09.014)
21. Cruzat VF, Rogero MM & Tirapegui J 2010 Effects of supplementation with free glutamine and the dipeptide alanyl-glutamine on parameters of muscle damage and inflammation in rats submitted to prolonged exercise. Cell Biochemistry and Function 28 24-30. (doi:10.1002/cbf. 1611)
22. Cruzat VF, Bittencourt A, Scomazzon SP, Leite JM, Homemde Bittencourt PI & Tirapegui J 2014 Oral free and dipeptide forms of glutamine supplementations attenuate oxidative stress and inflammation induced by endotoxemia. Nutrition 30 602-611. (doi:10.1016/j.nut. 2013.10.019)
23. Cruzat VF, Pantaleão LC, Donato J, de Bittencourt PIH & Tirapegui J 2014 Oral supplementations with free and dipeptide forms of L-glutamine in endotoxemic mice: effects on muscle glutamine-glutathione axis and heat shock proteins. Journal of Nutritional Biochemistry 25 345-352. (doi:10.1016/j.jnutbio.2013.11.009)
24. Cunha DA, Hekerman P, Ladriere L, Bazarra-Castro A, Ortis F, Wakeham MC, Moore F, Rasschaert J, Cardozo AK, Bellomo E et al. 2008 Initiation and execution of lipotoxic ER stress in pancreatic b-cells. Journal of Cell Science 121 2308-2318. (doi:10.1242/jcs.026062)
25. Danielsson A, Hellman B & Idahl LA 1970 Levels of -ketoglutarate and glutamate in stimulated pancreatic -cells. Hormone and Metabolic Research 2 28-31. (doi:10.1055/s-0028-1095123)
26. Deeney JT, Gromada J, Hoy M, Olsen HL, Rhodes CJ, Prentki M, Berggren PO & Corkey BE 2000 Acute stimulation with long chain acyl-CoA enhances exocytosis in insulin-secreting cells (HIT T-15 and NMRI b-cells). Journal of Biological Chemistry 275 9363-9368. (doi:10.1074/jbc. 275.13.9363)
27. De Vos A, Heimberg H, Quartier E, Huypens P, Bouwens L, Pipeleers D & Schuit F 1995 Human and rat b cells differ in glucose transporter but not in glucokinase gene expression. Journal of Clinical Investigation 96 2489-2495. (doi:10.1172/JCI118308)
28. Dixon G, Nolan J, McClenaghan N, Flatt PR & Newsholme P 2003 A comparative study of amino acid consumption by rat islet cells and the clonal b-cell line BRIN-BD11 - the functional significance of L-alanine. Journal of Endocrinology 179 447-454. (doi:10.1677/joe.0.1790447)
29. Donath MY & Shoelson SE 2011 Type 2 diabetes as an inflammatory disease. Nature Reviews. Immunology 11 98-9107. (doi:10.1038/nri2925)
30. Donath MY, Schumann DM, Faulenbach M, Ellingsgaard H, Perren A & Ehses JA 2008 Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care 31(Suppl 2) 161-164. (doi:10.2337/dc08-s243)s
31. Drummond MJ, Glynn EL, Fry CS, Timmerman KL, Volpi E & Rasmussen BB 2010 An increase in essential amino acid availability upregulates amino acid transporter expression in human skeletal muscle. American Journal of Physiology. Endocrinology andMetabolism 298 E1011-E1018. (doi:10.1152/ajpendo.00690.2009)
32. Dunne MJ, Yule DI, Gallacher DV & Petersen OH 1990 Effects of alanine on insulin-secreting cells: patch-clamp and single cell intracellular Ca2C measurements. Biochimica et Biophysica Acta 1055 157-164. (doi:10.1016/0167-4889(90)90116-U)
33. Flatt PR & Lenzen S 1994 Frontiers of Insulin Secretion and Pancreatic B-Cell Research. London, UK: Smith-Gordon Limiteds.
34. Fu Z, Gilbert ER & Liu D 2013 Regulation of insulin synthesis and secretion and pancreatic b-cell dysfunction in diabetes. Current Diabetes Reviews 9 25-53. (doi:10.2174/157339913804143225)
35. Gao D, Nong S, Huang X, Lu Y, Zhao H, Lin Y,Man Y, Wang S, Yang J & Li J 2010 The effects of palmitate on hepatic insulin resistance are mediated by NADPH oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways. Journal of Biological Chemistry 285 29965-29973. (doi:10.1074/jbc.M110.128694)
36. Gaudel C, Nongonierma AB, Maher S, Flynn S, Krause M, Murray BA, Kelly PM, Baird AW, Fitzgerald RJ & Newsholme P 2013 A whey protein hydrolysate promotes insulinotropic activity in a clonal pancreatic b-cell line and enhances glycemic function in ob/ob mice. Journal of Nutrition 143 1109-1114. (doi:10.3945/jn.113.174912)
37. Gembal M, Gilon P & Henquin JC 1992 Evidence that glucose can control insulin release independently from its action on ATP-sensitive KC channels in mouse B cells. Journal of Clinical Investigation 89 1288-1295. (doi:10.1172/JCI115714)
38. Gloyn AL, Odili S, Zelent D, Buettger C, Castleden HA, Steele AM, Stride A, Shiota C, Magnuson MA, Lorini R et al. 2005 Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young. Journal of Biological Chemistry 280 14105-14113. (doi:10.1074/jbc.M413146200)
39. Haber EP, Procopio J, Carvalho CR, Carpinelli AR, Newsholme P & Curi R 2006 New insights into fatty acid modulation of pancreatic b-cell function. International Review of Cytology 248 1-41.
40. Hamiel CR, Pinto S, Hau A & Wischmeyer PE 2009 Glutamine enhances heat shock protein 70 expression via increased hexosamine biosynthetic pathway activity. American Journal of Physiology. Cell Physiology 297 C1509-C1519. (doi:10.1152/ajpcell.00240.2009)
41. Hamilton JA & Kamp F 1999 How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids? Diabetes 48 2255-2269. (doi:10.2337/diabetes.48.12.2255)
42. Hasan NM, Longacre MJ, Stoker SW, Boonsaen T, Jitrapakdee S, Kendrick MA, Wallace JC & MacDonald MJ 2008 Impaired anaplerosis and insulin secretion in insulinoma cells caused by small interfering RNA-mediated suppression of pyruvate carboxylase. Journal of Biological Chemistry 283 28048-28059. (doi:10.1074/jbc.M804170200)
43. Henquin JC 2000 Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49 1751-1760. (doi:10.2337/diabetes.49.11.1751)
44. Hosokawa H, Corkey BE & Leahy JL 1997 b-cell hypersensitivity to glucose following 24-h exposure of rat islets to fatty acids. Diabetologia 40 392-397. (doi:10.1007/s001250050692)
45. Hotamisligil GS, Shargill NS & Spiegelman BM 1993 Adipose expression of tumor necrosis factor-a: direct role in obesity-linked insulin resistance. Science 259 87-91. (doi:10.1126/science.7678183)
46. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF & Spiegelman BM 1996 IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-a- and obesity-induced insulin resistance. Science 271 665-668. (doi:10.1126/science.271.5249.665)
47. Hoy M, Maechler P, Efanov AM, Wollheim CB, Berggren PO & Gromada J 2002 Increase in cellular glutamate levels stimulates exocytosis in pancreatic b-cells. FEBS Letters 531 199-203. (doi:10.1016/S0014-5793(02)03500-7)
48. Hu P, Thinschmidt JS, Yan Y, Hazra S, Bhatwadekar A, Caballero S, Salazar T, Miyan JA, Li W, Derbenev A et al. 2013 CNS inflammation and bone marrow neuropathy in type 1 diabetes. American Journal of Pathology 183 1608-1620. (doi:10.1016/j.ajpath.2013.07.009)
49. Itoh Y, Kawamata Y, Harada M, Kobayashi M, Fujii R, Fukusumi S, Ogi K, Hosoya M, Tanaka Y, Uejima H et al. 2003 Free fatty acids regulate insulin secretion from pancreatic b cells through GPR40. Nature 422 173-176. (doi:10.1038/nature01478)
50. Jakubowicz D & Froy O 2013 Biochemical and metabolic mechanisms by which dietary whey protein may combat obesity and type 2 diabetes. Journal of Nutritional Biochemistry 24 1-5. (doi:10.1016/j.jnutbio.2012. 07.008)
51. Jensen MV, Joseph JW, Ronnebaum SM, Burgess SC, Sherry AD & Newgard CB 2008 Metabolic cycling in control of glucose-stimulated insulin secretion. American Journal of Physiology, Endocrinology and Metabolism 295 E1287-E1297. (doi:10.1152/ajpendo.90604.2008)
52. Jitrapakdee S, Wutthisathapornchai A, Wallace JC & MacDonald MJ 2010 Regulation of insulin secretion: role of mitochondrial signalling. Diabetologia 53 1019-1032. (doi:10.1007/s00125-010-1685-0)
53. Kasabri V, Abu-Dahab R, Afifi FU, Naffa R & Majdalawi L 2012 Modulation of pancreatic MIN6 insulin secretion and proliferation and extrapancreatic glucose absorption with Achillea santolina, Eryngium creticum and Pistacia atlantica extracts: in vitro evaluation. Journal of Experimental and Integrative Medicine 2 245-254.
54. Keane DC, Takahashi HK, Dhayal S, Morgan NG, Curi R & Newsholme P 2011 Arachidonic acid actions on functional integrity and attenuation of the negative effects of palmitic acid in a clonal pancreatic b-cell line. Clinical Science 120 195-206. (doi:10.1042/CS20100282)
55. Komatsu M, Sato Y, Aizawa T & Hashizume K 2001 KATP channelindependent glucose action: an elusive pathway in stimulus-secretion coupling of pancreatic b-cell. Endocrine Journal 48 275-288. (doi:10.1507/endocrj.48.275)
56. Komatsu M, Takei M, Ishii H & Sato Y 2013 Glucose-stimulated insulin secretion: a newer perspective. Journal of Diabetes Investigation 4 511-516. (doi:10.1111/jdi.12094)
57. Krause MS, McClenaghan NH, Flatt PR, de Bittencourt PIH, Murphy C & Newsholme P 2011 L-arginine is essential for pancreatic b-cell functional integrity, metabolism and defense from inflammatory challenge. Journal of Endocrinology 211 87-97. (doi:10.1530/JOE-11-0236)
58. Krause M, Rodrigues-Krause J, O'Hagan C, De Vito G, Boreham C, Susta D, Newsholme P & Murphy C 2012 Differential nitric oxide levels in the blood and skeletal muscle of type 2 diabetic subjects may be consequence of adiposity: a preliminary study. Metabolism 61 1528-1537. (doi:10.1016/j.metabol.2012.05.003)
59. Lang F, Ullrich S & Gulbins E 2011 Ceramide formation as a target in b-cell survival and function. Expert Opinion on Therapeutic Targets 15 1061-1071. (doi:10.1517/14728222.2011.588209)
60. Latour MG, Alquier T, Oseid E, Tremblay C, Jetton TL, Luo J, Lin DC & Poitout V 2007 GPR40 is necessary but not sufficient for fatty acid stimulation of insulin secretion in vivo. Diabetes 56 1087-1094. (doi:10.2337/db06-1532)
61. Li C, Buettger C, Kwagh J, Matter A, Daikhin Y, Nissim IB, Collins HW, Yudkoff M, Stanley CA & Matschinsky FM 2004 A signaling role of glutamine in insulin secretion. Journal of Biological Chemistry 279 13393-13401. (doi:10.1074/jbc.M311502200)
62. Lu J, Xie G, Jia W & Jia W 2013 Insulin resistance and the metabolism of branched-chain amino acids. Frontiers of Medicine 7 53-59. (doi:10.1007/s11684-013-0255-5)
63. Lupi R, Dotta F, Marselli L, Del Guerra S, Masini M, Santangelo C, Patane G, Boggi U, Piro S, Anello M et al. 2002 Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that b-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51 1437-1442. (doi:10.2337/diabetes.51.5.1437)
64. Ma XM, Yoon SO, Richardson CJ, Julich K & Blenis J 2008 SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs. Cell 133 303-313. (doi:10.1016/j.cell. 2008.02.031)
65. Maassen JA, t Hart LM, Janssen GM, Reiling E, Romijn JA & Lemkes HH 2006 Mitochondrial diabetes and its lessons for common type 2 diabetes. Biochemical Society Transactions 34 819-823. (doi:10.1042/BST0340819)
66. MacDonald MJ & Fahien LA 2000 Glutamate is not a messenger in insulin secretion. Journal of Biological Chemistry 275 34025-34027. (doi:10.1074/jbc.C000411200)
67. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA & Donath MY 2002 Glucose-induced b cell production of IL-1b contributes to glucotoxicity in human pancreatic islets. Journal of Clinical Investigation 110 851-860. (doi:10.1172/JCI200215318)
68. Marmol P, Pardo B, Wiederkehr A, del Arco A, Wollheim CB & Satrustegui J 2009 Requirement for aralar and its Ca2C-binding sites in Ca2C signal transduction in mitochondria from INS-1 clonal b-cells. Journal of Biological Chemistry 284 515-524. (doi:10.1074/jbc.M806729200)
69. Masters SL 2013 Specific inflammasomes in complex diseases. Clinical Immunology 147 223-228. (doi:10.1016/j.clim.2012.12.006)
70. Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen Z et al. 2010 Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1b in type 2 diabetes. Nature Immunology 11 897-904. (doi:10.1038/ni.1935)
71. McClenaghan NH, Barnett CR & Flatt PR 1998 NaC cotransport by metabolizable and nonmetabolizable amino acids stimulates a glucoseregulated insulin-secretory response. Biochemical and Biophysical Research Communications 249 299-303. (doi:10.1006/bbrc.1998.9136)
72. McCluskey JT, Hamid M, Guo-Parke H, McClenaghan NH, Gomis R & Flatt PR 2011 Development and functional characterization of insulinreleasing human pancreatic b cell lines produced by electrofusion. Journal of Biological Chemistry 286 21982-21992. (doi:10.1074/jbc.M111.226795)
73. McCulloch LJ, van de Bunt M, Braun M, Frayn KN, Clark A & Gloyn AL 2011 GLUT2(SLC2A2) is not the principal glucose transporter in human pancreatic b cells: implications for understanding genetic association signals at this locus. Molecular Genetics and Metabolism 104 648-653. (doi:10.1016/j.ymgme.2011.08.026)
74. Menge BA, Schrader H, Ritter PR, Ellrichmann M, Uhl W, Schmidt WE & Meier JJ 2010 Selective amino acid deficiency in patients with impaired glucose tolerance and type 2 diabetes. Regulatory Peptides 160 75-80. (doi:10.1016/j.regpep.2009.08.001)
75. Miki T, Nagashima K, Tashiro F, Kotake K, Yoshitomi H, Tamamoto A, Gonoi T, Iwanaga T, Miyazaki J & Seino S 1998 Defective insulin secretion and enhanced insulin action in KATP channel-deficientmice. PNAS 95 10402-10406. (doi:10.1073/pnas.95.18.10402)
76. Morgan MJ & Liu ZG 2011 Crosstalk of reactive oxygen species and NF-kB signaling. Cell Research 21 103-115. (doi:10.1038/cr.2010.178)
77. Mulder H, Lu D, Finley JT, An J, Cohen J, Antinozzi PA, McGarry JD & Newgard CB 2001 Overexpression of a modified human malonyl-CoA decarboxylase blocks the glucose-induced increase in malonyl-CoA level but has no impact on insulin secretion in INS-1-derived (832/13) b-cells. Journal of Biological Chemistry 276 6479-6484. (doi:10.1074/jbc.M010364200)
78. Nader GA 2007 Muscle growth learns new tricks from an old dog. Nature Medicine 13 1016-1018. (doi:10.1038/nm0907-1016)
79. Nair KS, Ford GC, Ekberg K, Fernqvist-Forbes E & Wahren J 1995 Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients. Journal of Clinical Investigation 95 2926-2937. (doi:10.1172/JCI118000)
80. Nakagawa Y, Nagasawa M, Yamada S, Hara A, Mogami H, Nikolaev VO, Lohse MJ, Shigemura N, Ninomiya Y & Kojima I 2009 Sweet taste receptor expressed in pancreatic b-cells activates the calcium and cyclic AMP signaling systems and stimulates insulin secretion. PLoS ONE 4 e5106. (doi:10.1371/journal.pone.0005106)
81. Nakagawa Y, Nagasawa M, Mogami H, Lohse M, Ninomiya Y & Kojima I 2013 Multimodal function of the sweet taste receptor expressed in pancreatic b-cells: generation of diverse patterns of intracellular signals by sweet agonists. Endocrine Journal 60 1191-1206. (doi:10.1507/endocrj.EJ13-0282)
82. Newgard CB 2012 Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metabolism 15 606-614. (doi:10.1016/j.cmet.2012.01.024)
83. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA et al. 2009 A branched-chain amino acidrelated metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metabolism 9 311-326. (doi:10.1016/j.cmet.2009.02.002)
84. Newsholme P & Krause M 2012 Nutritional regulation of insulin secretion:implications for diabetes. Clinical Biochemist. Reviews 33 35-47.
85. Newsholme P, Bender K, Kiely A & Brennan L 2007a Amino acid metabolism, insulin secretion and diabetes. Biochemical Society Transactions 35 1180-1186. (doi:10.1042/BST0351180)
86. Newsholme P, Keane D, Welters HJ & Morgan NG 2007b Life and death decisions of the pancreatic b-cell: the role of fatty acids. Clinical Science 112 27-42. (doi:10.1042/CS20060115)
87. Newsholme P, Gaudel C & McClenaghan NH 2010 Nutrient regulation of insulin secretion and b-cell functional integrity. Advances in Experimental Medicine and Biology 654 91-114.
88. Newsholme P, Abdulkader F, Rebelato E, Romanatto T, Pinheiro CH, Vitzel KF, Silva EP, Bazotte RB, Procopio J, Curi R et al. 2011 Amino acids and diabetes: implications for endocrine, metabolic and immune function. Frontiers in Bioscience 16 315-339. (doi:10.2741/3690)
89. Newsholme P, Gaudel C & Krause M 2012a Mitochondria and diabetes. An intriguing pathogenetic role. Advances in Experimental Medicine and Biology 942 235-247. (doi:10.1007/978-94-007-2869-1_10)
90. Newsholme P, Rebelato E, Abdulkader F, Krause M, Carpinelli A & Curi R 2012b Reactive oxygen and nitrogen species generation, antioxidant defenses, and b-cell function: a critical role for amino acids. Journal of Endocrinology 214 11-20. (doi:10.1530/JOE-12-0072)
91. Nicastro H, da Luz CR, Chaves DF, Bechara LR, Voltarelli VA, Rogero MM& Lancha AH Jr 2012 Does branched-chain amino acids supplementation modulate skeletal muscle remodeling through inflammation modulation? Possible mechanisms of action Journal of Nutrition and Metabolism 2012 136937. (doi:10.1155/2012/136937)
92. Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, Nyfeler B, Yang H, Hild M, Kung C, Wilson C et al. 2009 Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136 521-534. (doi:10.1016/j.cell.2008.11.044)
93. Nielsen K, Sorensen PG, Hynne F & Busse HG 1998 Sustained oscillations in glycolysis: an experimental and theoretical study of chaotic and complex periodic behavior and of quenching of simple oscillations. Biophysical Chemistry 72 49-62. (doi:10.1016/S0301-4622(98)00122-7)
94. Nolan CJ & Prentki M 2008 The islet b-cell: fuel responsive and vulnerable. Trends in Endocrinology and Metabolism 19 285-291. (doi:10.1016/j.tem. 2008.07.006)
95. Nolan CJ, Madiraju MS, Delghingaro-Augusto V, Peyot ML & Prentki M 2006a Fatty acid signaling in the b-cell and insulin secretion. Diabetes 55(Suppl 2) S16-S23. (doi:10.2337/db06-S003)
96. Nolan CJ, Leahy JL, Delghingaro-Augusto V, Moibi J, Soni K, Peyot ML, Fortier M, Guay C, Lamontagne J, Barbeau A et al. 2006b b cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling. Diabetologia 49 2120-2130. (doi:10.1007/s00125-006-0305-5)
97. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM & Olefsky JM 2010 GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142 687-698. (doi:10.1016/j.cell.2010.07.041)
98. Ohanna M, Sobering AK, Lapointe T, Lorenzo L, Praud C, Petroulakis E, Sonenberg N, Kelly PA, Sotiropoulos A & Pende M 2005 Atrophy of S6K1 (K/K) skeletal muscle cells reveals distinctm TOR effectors for cell cycle and size control. Nature Cell Biology 7 286-294. (doi:10.1038/ncb1231)
99. Palacin M, Estevez R, Bertran J & Zorzano A 1998 Molecular biology of mammalian plasma membrane amino acid transporters. Physiological Reviews 78 969-1054.
100. Pratt WB, Morishima Y, Peng HM& Osawa Y 2010 Proposal for a role of the Hsp90/Hsp70-based chaperone machinery in making triage decisions when proteins undergo oxidative and toxic damage. Experimental Biology and Medicine 235 278-289. (doi:10.1258/ebm.2009.009250)
101. Remedi MS, Rocheleau JV, Tong A, Patton BL, McDaniel ML, Piston DW, Koster JC & Nichols CG 2006 Hyperinsulinism in mice with heterozygous loss of K(ATP) channels. Diabetologia 49 2368-2378. (doi:10.1007/s00125-006-0367-4)
102. Roduit R, Nolan C, Alarcon C, Moore P, Barbeau A, Delghingaro-Augusto V, Przybykowski E, Morin J, Masse F, Massie B et al. 2004 A role for the malonyl-CoA/long-chain acyl-CoA pathway of lipid signaling in the regulation of insulin secretion in response to both fuel and nonfuel stimuli. Diabetes 53 1007-1019. (doi:10.2337/diabetes.53.4.1007)
103. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD & Glass DJ 2001 Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nature Cell Biology 3 1009-1013. (doi:10.1038/ncb1101-1009)
104. Roos S, Lagerlof O, Wennergren M, Powell TL & Jansson T 2009 Regulation of amino acid transporters by glucose and growth factors in cultured primary human trophoblast cells is mediated by mTOR signaling. American Journal of Physiology. Cell Physiology 297 C723-C731. (doi:10.1152/ajpcell.00191.2009)
105. Rorsman P & Braun M 2013 Regulation of insulin secretion in human pancreatic islets. Annual Review of Physiology 75 155-179. (doi:10.1146/annurev-physiol-030212-183754)
106. Ruderman N & Prentki M 2004 AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nature Reviews. Drug Discovery 3 340-351. (doi:10.1038/nrd1344)
107. Russell ST, Rajani S, Dhadda RS & Tisdale MJ 2009 Mechanism of induction of muscle protein loss by hyperglycaemia. Experimental Cell Research 315 16-25. (doi:10.1016/j.yexcr.2008.10.002)
108. Sabio G, Kennedy NJ, Cavanagh-Kyros J, Jung DY, Ko HJ, Ong H, Barrett T, Kim JK & Davis RJ 2010 Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulin resistance. Molecular and Cellular Biology 30 106-115. (doi:10.1128/MCB.01162-09)
109. Salvucci M, Neufeld Z & Newsholme P 2013 Mathematical model of metabolism and electrophysiology of amino acid and glucose stimulated insulin secretion: in vitro validation using a b-cell line. PLoS ONE 8 e52611. (doi:10.1371/journal.pone.0052611)
110. Sartorelli V & Fulco M 2004 Molecular and cellular determinants of skeletal muscle atrophy and hypertrophy. Science's STKE 2004 re11.
111. Sato Y, Aizawa T, Komatsu M, Okada N & Yamada T 1992 Dual functional role of membrane depolarization/Ca2C influx in rat pancreatic B-cell. Diabetes 41 438-443. (doi:10.2337/diab.41.4.438)
112. Sener A & Malaisse WJ 1980 L-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase. Nature 288 187-189. (doi:10.1038/288187a0)
113. Sener A, Best LC, Yates AP, Kadiata MM, Olivares E, Louchami K, Jijakli H, Ladriere L & Malaisse WJ 2000 Stimulus-secretion coupling of arginineinduced insulin release: comparison between the cationic amino acid and its methyl ester. Endocrine 13 329-340. (doi:10.1385/ENDO:13:3:329)
114. Shapiro H, Shachar S, Sekler I, Hershfinkel M & Walker MD 2005 Role of GPR40 in fatty acid action on the b cell line INS-1E. Biochemical and Biophysical Research Communications 335 97-9104. (doi:10.1016/j.bbrc. 2005.07.042)
115. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA & Shulman RG 1990 Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. New England Journal of Medicine 322 223-228. (doi:10.1056/NEJM199001253220403)
116. Sugden MC & Holness MJ 2011 The pyruvate carboxylase-pyruvate dehydrogenase axis in islet pyruvate metabolism: going round in circles? Islets 3 302-319. (doi:10.4161/isl.3.6.17806)
117. Taniguchi CM, Emanuelli B & Kahn CR 2006 Critical nodes in signalling pathways: insights into insulin action. Nature Reviews. Molecular Cell Biology 7 85-96. (doi:10.1038/nrm1837)
118. Tateya S, Kim F & Tamori Y 2013 Recent advances in obesity-induced inflammation and insulin resistance. Frontiers in Endocrinology 4 93. (doi:10.3389/fendo.2013.00093)
119. Tomita T, Masuzaki H, Iwakura H, Fujikura J, Noguchi M, Tanaka T, Ebihara K, Kawamura J, Komoto I, Kawaguchi Y et al. 2006 Expression of the gene for a membrane-bound fatty acid receptor in the pancreas and islet cell tumours in humans: evidence for GPR40 expression in pancreatic b cells and implications for insulin secretion. Diabetologia 49 962-968. (doi:10.1007/s00125-006-0193-8)
120. Towler MC & Hardie DG 2007 AMP-activated protein kinase in metabolic control and insulin signaling. Circulation Research 100 328-341. (doi:10.1161/01.RES.0000256090.42690.05)
121. Tremblay A & Gilbert JA 2009 Milk products, insulin resistance syndrome and type 2 diabetes. Journal of the American College of Nutrition 28(Suppl 1) 91S-102S. (doi:10.1080/07315724.2009.10719809)
122. Turley S, Poirot L, Hattori M, Benoist C & Mathis D 2003 Physiological b cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. Journal of Experimental Medicine 198 1527-1537. (doi:10.1084/jem.20030966)
123. Usher-Smith JA, Huang CLH & Fraser JA 2009 Control of cell volume in skeletal muscle. Biological Reviews 84 143-159. (doi:10.1111/j.1469-185X.2008.00066.x)
124. Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM & Dixit VD 2011 The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nature Medicine 17 179-188. (doi:10.1038/nm.2279)
125. Vassiliou E, Gonzalez A, Garcia C, Tadros J, Chakraborty G & Toney J 2009 Oleic acid and peanut oil high in oleic acid reverse the inhibitory effect of insulin production of the inflammatory cytokine TNF-a both in vitro and in vivo systems. Lipids in Health and Disease 8 25. (doi:10.1186/1476-511X-8-25)
126. van der Velden JL, Langen RC, Kelders MC, Willems J, Wouters EF, Janssen-Heininger YM & Schols AM 2007 Myogenic differentiation during regrowth of atrophied skeletal muscle is associated with inactivation of GSK-3b. American Journal of Physiology. Cell Physiology 292 C1636-C1644. (doi:10.1152/ajpcell.00504.2006)
127. Welsh N, Cnop M, Kharroubi I, Bugliani M, Lupi R, Marchetti P & Eizirik DL 2005 Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets? Diabetes 54 3238-3244. (doi:10.2337/diabetes.54.11.3238)
128. Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, Brickey WJ & Ting JP 2011 Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nature Immunology 12 408-415. (doi:10.1038/ni.2022)
129. Westermark PO & Lansner A 2003 A model of phosphofructokinase and glycolytic oscillations in the pancreatic b-cell. Biophysical Journal 85 126-139. (doi:10.1016/S0006-3495(03)74460-9)
130. White MF 2003 Insulin signaling in health and disease. Science 302 1710-1711. (doi:10.1126/science.1092952)
131. Whiting DR, Guariguata L, Weil C & Shaw J 2011 IDF diabetes atlas:global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice 94 311-321. (doi:10.1016/j.diabres.2011.10.029)
132. Wierup N, Sundler F & Heller RS 2014 The islet ghrelin cell. Journal of Molecular Endocrinology 52 R35-R49. (doi:10.1530/JME-13-0122)
133. Wijekoon EP, Skinner C, Brosnan ME & Brosnan JT 2004 Amino acid metabolism in the Zucker diabetic fatty rat: effects of insulin resistance and of type 2 diabetes. Canadian Journal of Physiology and Pharmacology 82 506-514. (doi:10.1139/y04-067)
134. Xu J, Han J, Long YS, Epstein PN & Liu YQ 2008 The role of pyruvate carboxylase in insulin secretion and proliferation in rat pancreatic b cells. Diabetologia 51 2022-2030. (doi:10.1007/s00125-008-1130-9)
135. Yang J, Wong RK, Park M, Wu J, Cook JR, York DA, Deng S, Markmann J, Naji A, Wolf BA et al. 2006 Leucine regulation of glucokinase and ATP synthase sensitizes glucose-induced insulin secretion in pancreatic b-cells. Diabetes 55 193-201. (doi:10.2337/diabetes.55.01.06.db05-0938)
136. Yano M, Inoue M, Maehata E, Shiba T, Yamakado M, Hirabayashi Y, Taniyama M & Suzuki S 2004 Increased electronegative charge of serum low-density lipoprotein in patients with diabetes mellitus. Clinica Chimica Acta 340 93-98. (doi:10.1016/j.cccn.2003.09.020)
137. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L & Friedman JM 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372 425-432. (doi:10.1038/372425a0)
138. Zhang X, Xu A, Chung SK, Cresser JH, Sweeney G, Wong RL, Lin A & Lam KS 2011 Selective inactivation of c-Jun NH2-terminal kinase in adipose tissue protects against diet-induced obesity and improves insulin sensitivity in both liver and skeletal muscle inmice. Diabetes 60 486-495. (doi:10.2337/db10-0650)